Genialis
Genialis is a precision oncology company leveraging advanced AI and deep biological expertise to develop and validate clinically actionable RNA biomarkers. The company's mission is to transform medicine by creating innovative tools that improve patient outcomes, support drug development, and enable personalized treatment strategies. With a focus on RNA data and machine learning, Genialis collaborates with pharma, diagnostics, and research partners to enhance translational decision-making, optimize clinical trials, and develop new therapies.
Industries
Nr. of Employees
small (1-50)
Genialis
Boston, Massachusetts, United States, North America
Products
Foundation cancer biology model (RNA LMM)
A foundation (large molecular) model trained on large, diverse RNA-seq datasets that projects samples into interpretable biology-space for rapid biomarker configuration.
KRAS-response RNA classifier (preconfigured and tunable)
A preconfigured RNA-based classifier designed to predict and stratify clinical benefit for KRAS-targeted therapies; validated on preclinical and real-world cohorts and tunable to compound-specific datasets.
Sequencing data management and analysis platform
A software platform that implements validated pipelines, QC/QA, normalization, and data aggregation to produce ML-ready datasets and visualizations via code-free modules or programmatic API.
Foundation cancer biology model (RNA LMM)
A foundation (large molecular) model trained on large, diverse RNA-seq datasets that projects samples into interpretable biology-space for rapid biomarker configuration.
KRAS-response RNA classifier (preconfigured and tunable)
A preconfigured RNA-based classifier designed to predict and stratify clinical benefit for KRAS-targeted therapies; validated on preclinical and real-world cohorts and tunable to compound-specific datasets.
Sequencing data management and analysis platform
A software platform that implements validated pipelines, QC/QA, normalization, and data aggregation to produce ML-ready datasets and visualizations via code-free modules or programmatic API.
Services
Therapeutic intelligence and biomarker discovery service
End-to-end service to identify predictive RNA biomarkers, elucidate mechanisms of action and resistance, and produce clinically actionable patient stratification strategies for preclinical and clinical programs.
Off-the-shelf and tunable predictive classifiers
Preconfigured or compound‑tuned RNA-based classifiers to predict response for specific targets or MOAs; can be adapted to client datasets for translational and clinical development.
Sequencing data infrastructure and deployment
Deployment and operation of a FAIR data platform and validated bioinformatics pipelines for NGS data, available on the provider cloud or as private cloud deployment with cybersecurity controls.
Therapeutic intelligence and biomarker discovery service
End-to-end service to identify predictive RNA biomarkers, elucidate mechanisms of action and resistance, and produce clinically actionable patient stratification strategies for preclinical and clinical programs.
Off-the-shelf and tunable predictive classifiers
Preconfigured or compound‑tuned RNA-based classifiers to predict response for specific targets or MOAs; can be adapted to client datasets for translational and clinical development.
Sequencing data infrastructure and deployment
Deployment and operation of a FAIR data platform and validated bioinformatics pipelines for NGS data, available on the provider cloud or as private cloud deployment with cybersecurity controls.
Expertise Areas
- RNA-based biomarker development and validation
- AI/ML for oncology and biomarker discovery
- Clinical trial design and patient stratification
- Sequencing data analysis and bioinformatics
Key Technologies
- Large molecular/foundation models trained on RNA-seq
- Machine learning classifiers for treatment response
- RNA-seq and multi-omics analysis pipelines
- Bias-correction and data harmonization algorithms